Clinical Pharmacology Studies in Critically Ill Children.

Published

Journal Article (Review)

Developmental and physiological changes in children contribute to variation in drug disposition with age. Additionally, critically ill children suffer from various life-threatening conditions that can lead to pathophysiological alterations that further affect pharmacokinetics (PK). Some factors that can alter PK in this patient population include variability in tissue distribution caused by protein binding changes and fluid shifts, altered drug elimination due to organ dysfunction, and use of medical interventions that can affect drug disposition (e.g., extracorporeal membrane oxygenation and continuous renal replacement therapy). Performing clinical studies in critically ill children is challenging because there is large inter-subject variability in the severity and time course of organ dysfunction; some critical illnesses are rare, which can affect subject enrollment; and critically ill children usually have multiple organ failure, necessitating careful selection of a study design. As a result, drug dosing in critically ill children is often based on extrapolations from adults or non-critically ill children. Dedicated clinical studies in critically ill children are urgently needed to identify optimal dosing of drugs in this vulnerable population. This review will summarize the effect of critical illness on pediatric PK, the challenges associated with performing studies in this vulnerable subpopulation, and the clinical PK studies performed to date for commonly used drugs.

Full Text

Duke Authors

Cited Authors

  • Thakkar, N; Salerno, S; Hornik, CP; Gonzalez, D

Published Date

  • January 2017

Published In

Volume / Issue

  • 34 / 1

Start / End Page

  • 7 - 24

PubMed ID

  • 27585904

Pubmed Central ID

  • 27585904

Electronic International Standard Serial Number (EISSN)

  • 1573-904X

Digital Object Identifier (DOI)

  • 10.1007/s11095-016-2033-y

Language

  • eng

Conference Location

  • United States